NASDAQ:IMI - Intermolecular Stock Price, Price Target & More

$1.32 +0.01 (+0.76 %)
(As of 04/20/2018 02:12 PM ET)
Previous Close$1.31
Today's Range$1.25 - $1.35
52-Week Range$0.80 - $1.65
Volume9,397 shs
Average Volume46,099 shs
Market Capitalization$62.99 million
P/E RatioN/A
Dividend YieldN/A
Beta1.08

About Intermolecular (NASDAQ:IMI)

Intermolecular logoIntermolecular, Inc. engages in the development of advanced materials using high productivity combinatorial (HPC) technology platform for the semiconductors, consumer electronics, automotive, and aerospace industries worldwide. The company's HPC platform includes Tempus processing tools, automated characterization methods, and informatics analysis software for research and development using combinatorial process systems in concert with established chemical vapor deposition, physical vapor deposition, and atomic layer deposition methods. It serves various markets, including semiconductor, glass, advanced alloys, light-emitting diodes, flat-panel displays, and others. The company was formerly known as The BEP Group, Inc. and changed its name to Intermolecular, Inc. in November 2004. Intermolecular, Inc. was founded in 2004 and is headquartered in San Jose, California.

Receive IMI News and Ratings via Email

Sign-up to receive the latest news and ratings for IMI and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Semiconductors & related devices
Sub-IndustrySemiconductors
SectorComputer and Technology
SymbolNASDAQ:IMI
CUSIP45882D10
Phone408-582-5700

Debt

Debt-to-Equity RatioN/A
Current Ratio5.84%
Quick Ratio5.84%

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual Sales$37.20 million
Price / Sales1.76
Cash FlowN/A
Price / CashN/A
Book Value$0.73 per share
Price / Book1.81

Profitability

EPS (Most Recent Fiscal Year)N/A
Net Income$-10,400,000.00
Net Margins-27.96%
Return on Equity-27.94%
Return on Assets-22.35%

Miscellaneous

Employees105
Outstanding Shares49,600,000

How to Become a New Pot Stock Millionaire

Intermolecular (NASDAQ:IMI) Frequently Asked Questions

What is Intermolecular's stock symbol?

Intermolecular trades on the NASDAQ under the ticker symbol "IMI."

How were Intermolecular's earnings last quarter?

Intermolecular Inc (NASDAQ:IMI) released its quarterly earnings data on Tuesday, February, 13th. The semiconductor company reported $0.01 earnings per share for the quarter, topping the consensus estimate of ($0.02) by $0.03. The semiconductor company had revenue of $10.55 million for the quarter. Intermolecular had a negative net margin of 27.96% and a negative return on equity of 27.94%. View Intermolecular's Earnings History.

When is Intermolecular's next earnings date?

Intermolecular is scheduled to release their next quarterly earnings announcement on Wednesday, May, 2nd 2018. View Earnings Estimates for Intermolecular.

Who are some of Intermolecular's key competitors?

Who are Intermolecular's key executives?

Intermolecular's management team includes the folowing people:
  • Dr. Bruce M. McWilliams Ph.D., Non Exec. Chairman & Consultant (Age 62)
  • Mr. Christian F. Kramer, Chief Exec. Officer, Pres & Director (Age 56)
  • Mr. C. Richard Neely Jr., Consultant (Age 64)
  • Mr. Bill Roeschlein, CFO & Principal Accounting Officer (Age 48)
  • Mr. Milind Weling, Sr. VP of Programs & Operations

Has Intermolecular been receiving favorable news coverage?

Media headlines about IMI stock have trended somewhat positive recently, Accern Sentiment reports. The research group identifies negative and positive press coverage by analyzing more than 20 million news and blog sources in real-time. Accern ranks coverage of public companies on a scale of negative one to one, with scores closest to one being the most favorable. Intermolecular earned a media sentiment score of 0.12 on Accern's scale. They also assigned news coverage about the semiconductor company an impact score of 45.41 out of 100, meaning that recent press coverage is somewhat unlikely to have an impact on the company's share price in the next few days.

How do I buy shares of Intermolecular?

Shares of IMI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Intermolecular's stock price today?

One share of IMI stock can currently be purchased for approximately $1.32.

How big of a company is Intermolecular?

Intermolecular has a market capitalization of $62.99 million and generates $37.20 million in revenue each year. Intermolecular employs 105 workers across the globe.

How can I contact Intermolecular?

Intermolecular's mailing address is 3011 NORTH FIRST STREET, SAN JOSE CA, 95134. The semiconductor company can be reached via phone at 408-582-5700 or via email at [email protected]


MarketBeat Community Rating for Intermolecular (IMI)

Community Ranking:  2.0 out of 5 (star star)
Outperform Votes:  89 (Vote Outperform)
Underperform Votes:  131 (Vote Underperform)
Total Votes:  220
MarketBeat's community ratings are surveys of what our community members think about Intermolecular and other stocks. Vote "Outperform" if you believe IMI will outperform the S&P 500 over the long term. Vote "Underperform" if you believe IMI will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Intermolecular (NASDAQ:IMI) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: N/AN/AHoldHold
Consensus Rating Score: N/AN/A2.002.00
Ratings Breakdown: 0 Sell Rating(s)
0 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: N/AN/AN/AN/A
Price Target Upside: N/AN/AN/AN/A

Intermolecular (NASDAQ:IMI) Consensus Price Target History

Price Target History for Intermolecular (NASDAQ:IMI)

Intermolecular (NASDAQ:IMI) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
2/16/2017Needham & Company LLCReiterated RatingHoldN/AView Rating Details
(Data available from 4/20/2016 forward)

Earnings

Intermolecular (NASDAQ:IMI) Earnings History and Estimates Chart

Earnings by Quarter for Intermolecular (NASDAQ:IMI)

Intermolecular (NASDAQ IMI) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
5/2/2018($0.03)N/AView Earnings Details
2/13/2018Q4 2017($0.02)$0.01$10.55 millionViewListenView Earnings Details
11/2/2017Q3 2017($0.04)$8.62 millionViewN/AView Earnings Details
8/8/2017Q2 2017($0.06)$8.09 millionViewN/AView Earnings Details
5/4/2017Q1 2017($0.12)$9.95 millionViewN/AView Earnings Details
2/9/2017Q416($0.08)($0.05)$10.20 million$10.50 millionViewListenView Earnings Details
11/2/2016Q3 2016($0.13)($0.14)$10.57 millionViewN/AView Earnings Details
8/4/2016Q2 2016($0.08)$10.05 millionViewN/AView Earnings Details
5/5/2016Q1 2016($0.09)($0.03)$14.00 million$14.52 millionViewN/AView Earnings Details
2/4/2016Q4 2015($0.11)($0.04)$12.55 million$13.46 millionViewN/AView Earnings Details
11/5/2015Q3 2015($0.12)($0.12)$11.20 million$11.53 millionViewN/AView Earnings Details
8/6/2015Q2 2015($0.12)$10.50 million$10.99 millionViewN/AView Earnings Details
5/7/2015Q1 2015($0.16)($0.15)$9.60 million$9.85 millionViewN/AView Earnings Details
2/12/2015Q414($0.10)($0.10)$10.40 million$11.00 millionViewN/AView Earnings Details
10/31/2014Q314($0.09)($0.07)$10.60 million$10.90 millionViewN/AView Earnings Details
8/1/2014Q2 2014($0.19)($0.14)$9.00 million$9.93 millionViewN/AView Earnings Details
5/6/2014Q1($0.05)($0.06)$15.51 million$15.91 millionViewN/AView Earnings Details
2/6/2014($0.07)($0.07)$15.57 million$15.60 millionViewN/AView Earnings Details
2/6/2014($0.07)($0.07)$15.57 million$15.60 millionViewN/AView Earnings Details
2/6/2014Q413($0.07)($0.07)$15.57 million$15.60 millionViewN/AView Earnings Details
10/24/2013Q313($0.03)($0.05)$15.50 million$17.70 millionViewN/AView Earnings Details
7/25/2013Q213($0.01)$0.01$16.54 million$16.60 millionViewN/AView Earnings Details
4/25/2013Q1 2013$0.03$16.97 million$17.43 millionViewN/AView Earnings Details
2/7/2013Q4 2013$0.01$0.03$16.68 million$17.40 millionViewN/AView Earnings Details
10/25/2012($0.03)$0.02ViewN/AView Earnings Details
7/26/2012($0.03)($0.02)ViewN/AView Earnings Details
2/7/2012Q4 2011($0.04)($0.02)ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Dividends

Intermolecular (NASDAQ:IMI) Dividend History by Quarter

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

Intermolecular (NASDAQ IMI) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 45.40%
Institutional Ownership Percentage: 37.32%
Insider Trading History for Intermolecular (NASDAQ:IMI)
Institutional Ownership by Quarter for Intermolecular (NASDAQ:IMI)

Intermolecular (NASDAQ IMI) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
9/7/2017Lloyd I Miller IIIMajor ShareholderBuy600$0.86$516.0070,368View SEC Filing  
9/5/2017Lloyd I Miller IIIMajor ShareholderBuy1,909$0.86$1,641.7470,368View SEC Filing  
9/1/2017Lloyd I Miller IIIMajor ShareholderBuy34,109$0.86$29,333.7470,368View SEC Filing  
8/31/2017Lloyd I Miller IIIMajor ShareholderBuy1,612$0.86$1,386.3270,368View SEC Filing  
8/28/2017Lloyd I Miller IIIMajor ShareholderBuy400$0.86$344.0070,368View SEC Filing  
8/21/2017Lloyd I Miller IIIMajor ShareholderBuy300$0.86$258.0070,368View SEC Filing  
6/22/2017Lloyd I Miller IIIMajor ShareholderBuy80,000$0.88$70,400.0070,368View SEC Filing  
6/20/2017Lloyd I Miller IIIMajor ShareholderBuy6,659$0.86$5,726.7470,368View SEC Filing  
5/24/2017Lloyd I Miller IIIMajor ShareholderBuy107$0.85$90.9570,368View SEC Filing  
5/23/2017Lloyd I Miller IIIMajor ShareholderBuy29,020$0.85$24,667.0070,368View SEC Filing  
5/22/2017Lloyd I Miller IIIMajor ShareholderBuy5,590$0.85$4,751.5070,368View SEC Filing  
5/19/2017Lloyd I Miller IIIMajor ShareholderBuy6,564$0.85$5,579.4070,368View SEC Filing  
5/18/2017Lloyd I Miller IIIMajor ShareholderBuy2,132$0.85$1,812.2070,368View SEC Filing  
5/17/2017Lloyd I Miller IIIMajor ShareholderBuy12,743$0.85$10,831.5570,368View SEC Filing  
5/16/2017Lloyd I Miller IIIMajor ShareholderBuy9,325$0.85$7,926.2570,368View SEC Filing  
5/15/2017Lloyd I Miller IIIMajor ShareholderBuy8,817$0.85$7,494.4570,368View SEC Filing  
5/12/2017Lloyd I Miller IIIMajor ShareholderBuy4,642$0.85$3,945.7070,368View SEC Filing  
2/28/2017Rick NeelyCFOSell1,145$1.02$1,167.9083,601View SEC Filing  
12/16/2016William C MartinMajor ShareholderBuy214,294$1.02$218,579.88View SEC Filing  
11/18/2016William C MartinMajor ShareholderBuy400$1.00$400.00View SEC Filing  
11/17/2016William C MartinMajor ShareholderBuy990,452$0.85$841,884.20View SEC Filing  
10/14/2016Rick NeelyCFOSell4,586$0.95$4,356.7082,246View SEC Filing  
8/15/2016Irwin FedermanDirectorBuy100,000$1.25$125,000.00376,607View SEC Filing  
8/12/2016William C MartinMajor ShareholderBuy10,944$1.25$13,680.00View SEC Filing  
8/11/2016William C MartinMajor ShareholderBuy2,165,634$1.02$2,208,946.68View SEC Filing  
5/17/2016Irwin FedermanDirectorBuy100,000$1.90$190,000.00355,897View SEC Filing  
3/1/2016Rick NeelyCFOSell940$2.18$2,049.2086,832View SEC Filing  
2/24/2016Irwin FedermanDirectorBuy5,900$2.12$12,508.00255,897View SEC Filing  
2/16/2016Irwin FedermanDirectorBuy4,716$2.12$9,997.92249,997View SEC Filing  
2/11/2016Irwin FedermanDirectorBuy17,878$2.10$37,543.80245,281View SEC Filing  
12/9/2015Irwin FedermanDirectorBuy5,603$2.05$11,486.15227,403View SEC Filing  
12/8/2015Irwin FedermanDirectorBuy1,600$2.04$3,264.00227,403View SEC Filing  
12/7/2015Irwin FedermanDirectorBuy200$2.05$410.00227,403View SEC Filing  
11/17/2015Irwin FedermanDirectorBuy4,600$2.03$9,338.00218,900View SEC Filing  
11/16/2015Irwin FedermanDirectorBuy64,300$2.00$128,600.00214,300View SEC Filing  
10/5/2015Rick NeelyCFOSell3,807$1.86$7,081.0298,902View SEC Filing  
9/23/2015William C MartinMajor ShareholderBuy283,913$1.75$496,847.75View SEC Filing  
6/25/2015Rick NeelyCFOSell33,407$1.95$65,143.65View SEC Filing  
11/13/2014Irwin FedermanDirectorBuy50,000$2.14$107,000.00View SEC Filing  
11/4/2014Irwin FedermanDirectorBuy100,000$2.25$225,000.00View SEC Filing  
10/3/2014Rick NeelyCFOSell3,884$2.31$8,972.04View SEC Filing  
7/29/2014Hector Thomas BlancoVPSell3,032$2.24$6,791.68View SEC Filing  
7/23/2014Hector Thomas BlancoVPSell1,968$2.20$4,329.60View SEC Filing  
5/1/2014Sandeep JaggiSVPSell5,569$2.70$15,036.3098,617View SEC Filing  
3/31/2014Raj JammySVPSell5,356$2.76$14,782.5659,644View SEC Filing  
3/3/2014Tony ChiangCTOSell1,476$2.64$3,896.64278,797View SEC Filing  
2/6/2014David LazovskyCEOSell4,552$4.02$18,299.042,745,638View SEC Filing  
1/28/2014Sandeep JaggiSVPSell2,322$4.06$9,427.3277,978View SEC Filing  
1/28/2014Sandeep NijhawanVPSell4,064$4.06$16,499.84106,086View SEC Filing  
1/28/2014Tony ChiangCTOSell1,742$4.06$7,072.52260,273View SEC Filing  
12/10/2013David LazovskyCEOSell38,500$5.33$205,205.002,750,190View SEC Filing  
12/4/2013Tony ChiangCTOSell30,000$5.52$165,600.0076,775View SEC Filing  
11/8/2013David LazovskyCEOSell38,500$5.58$214,830.002,788,690View SEC Filing  
10/8/2013David LazovskyCEOSell38,500$5.80$223,300.002,827,190View SEC Filing  
9/9/2013David E LazovskyCEOSell38,500$5.89$226,765.00View SEC Filing  
9/5/2013Tony ChiangCTOSell39,003$5.97$232,847.9176,775View SEC Filing  
8/7/2013David LazovskyCEOSell38,500$6.20$238,700.002,904,190View SEC Filing  
8/1/2013Tony P ChiangCTOSell48,000$6.31$302,880.00View SEC Filing  
7/16/2013Peter L EidelmanCFOSell21,753$6.96$151,400.88View SEC Filing  
7/8/2013David E LazovskyCEOSell38,500$7.34$282,590.00View SEC Filing  
7/3/2013Tony P ChiangCTOSell78,000$7.23$563,940.00View SEC Filing  
6/17/2013Peter L EidelmanCFOSell6,500$7.30$47,450.00View SEC Filing  
6/7/2013David E LazovskyCEOSell38,500$8.22$316,470.00View SEC Filing  
6/3/2013James Craig HunterSVPSell3,500$8.43$29,505.00View SEC Filing  
5/23/2013Tony P ChiangCTOSell52,926$8.40$444,578.40View SEC Filing  
5/16/2013Peter L EidelmanCFOSell6,500$8.68$56,420.00View SEC Filing  
3/25/2013Tony P ChiangCTOSell25,000$9.53$238,250.00View SEC Filing  
2/26/2013Tony P ChiangCTOSell72,612$9.55$693,444.60View SEC Filing  
2/21/2013Bruce M McwilliamsDirectorSell2,132$9.64$20,552.48View SEC Filing  
1/17/2013Bruce M McwilliamsDirectorSell21,200$9.27$196,524.00View SEC Filing  
12/3/2012John R BehnkeSVPSell2,500$6.99$17,475.00View SEC Filing  
10/8/2012David E LazovskyCEOSell26,810$7.23$193,836.30View SEC Filing  
9/5/2012James Craig HunterSVPSell3,500$7.20$25,200.00View SEC Filing  
8/23/2012Tony P ChiangCTOSell14,266$7.15$102,001.90View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Intermolecular (NASDAQ IMI) News Headlines

Source:
DateHeadline
Intermolecular Sets Fiscal First Quarter 2018 Earnings Call for Tuesday, May 8, 2018 at 5 p.m. ETIntermolecular Sets Fiscal First Quarter 2018 Earnings Call for Tuesday, May 8, 2018 at 5 p.m. ET
finance.yahoo.com - April 19 at 10:17 AM
Intermolecular to Present at The MicroCap Conference on April 10, 2018Intermolecular to Present at The MicroCap Conference on April 10, 2018
finance.yahoo.com - March 28 at 10:31 AM
Financial Review: Intermolecular (IMI) vs. Itron (ITRI)Financial Review: Intermolecular (IMI) vs. Itron (ITRI)
www.americanbankingnews.com - March 27 at 1:28 AM
Edited Transcript of IMI earnings conference call or presentation 13-Feb-18 10:00pm GMTEdited Transcript of IMI earnings conference call or presentation 13-Feb-18 10:00pm GMT
finance.yahoo.com - March 18 at 10:16 AM
Texas Instruments (TXN) and Intermolecular (IMI) Critical ReviewTexas Instruments (TXN) and Intermolecular (IMI) Critical Review
www.americanbankingnews.com - March 10 at 3:22 PM
Silicon Image (SIMG) & Intermolecular (IMI) Head-To-Head ContrastSilicon Image (SIMG) & Intermolecular (IMI) Head-To-Head Contrast
www.americanbankingnews.com - February 24 at 9:12 PM
Intermolecular (IMI) Announces Quarterly  Earnings Results, Beats Expectations By $0.03 EPSIntermolecular (IMI) Announces Quarterly Earnings Results, Beats Expectations By $0.03 EPS
www.americanbankingnews.com - February 14 at 12:26 PM
Intermolecular posts 4Q profitIntermolecular posts 4Q profit
finance.yahoo.com - February 14 at 8:38 AM
Intermolecular Reports Fourth Quarter and Full Year 2017 Financial ResultsIntermolecular Reports Fourth Quarter and Full Year 2017 Financial Results
finance.yahoo.com - February 13 at 5:02 PM
Intermolecular (IMI) to Release Quarterly Earnings on WednesdayIntermolecular (IMI) to Release Quarterly Earnings on Wednesday
www.americanbankingnews.com - January 31 at 2:28 AM
BRIEF-Intermolecular, Sitri Expand Strategic AllianceBRIEF-Intermolecular, Sitri Expand Strategic Alliance
www.reuters.com - January 23 at 4:42 PM
Intermolecular and SITRI Expand Strategic Alliance to Accelerate Development of Advanced Memory Technologies for the China MarketIntermolecular and SITRI Expand Strategic Alliance to Accelerate Development of Advanced Memory Technologies for the China Market
www.prnewswire.com - January 22 at 7:25 PM
Intermolecular Sets Fiscal Fourth Quarter and Full Year 2017 Earnings Call for Tuesday, February 13, 2018 at 5 p.m. ETIntermolecular Sets Fiscal Fourth Quarter and Full Year 2017 Earnings Call for Tuesday, February 13, 2018 at 5 p.m. ET
finance.yahoo.com - January 17 at 10:49 AM
Intermolecular To Present At 20th Annual Needham Growth ConferenceIntermolecular To Present At 20th Annual Needham Growth Conference
finance.yahoo.com - January 4 at 10:47 AM
Intermolecular (IMI) Raised to Hold at ValuEngineIntermolecular (IMI) Raised to Hold at ValuEngine
www.americanbankingnews.com - January 1 at 8:14 PM
Head-To-Head Analysis: CEVA (CEVA) and Intermolecular (IMI)Head-To-Head Analysis: CEVA (CEVA) and Intermolecular (IMI)
www.americanbankingnews.com - December 28 at 5:04 PM
ETFs with exposure to Intermolecular, Inc. : December 28, 2017ETFs with exposure to Intermolecular, Inc. : December 28, 2017
finance.yahoo.com - December 28 at 1:50 PM
ETFs with exposure to Intermolecular, Inc. : November 21, 2017ETFs with exposure to Intermolecular, Inc. : November 21, 2017
finance.yahoo.com - November 21 at 8:02 PM
Intermolecular and SITRI Form Strategic Alliance to Accelerate Materials Innovation - "More than Moore"Intermolecular and SITRI Form Strategic Alliance to Accelerate Materials Innovation - "More than Moore"
finance.yahoo.com - November 20 at 8:15 PM
Intermolecular To Participate In The Sixth Annual NYC Investor Summit 2017Intermolecular To Participate In The Sixth Annual NYC Investor Summit 2017
finance.yahoo.com - November 17 at 6:32 AM
Intermolecular, Inc. :IMI-US: Earnings Analysis: Q3, 2017 By the Numbers : November 9, 2017Intermolecular, Inc. :IMI-US: Earnings Analysis: Q3, 2017 By the Numbers : November 9, 2017
finance.yahoo.com - November 11 at 11:54 AM
ETFs with exposure to Intermolecular, Inc. : November 10, 2017ETFs with exposure to Intermolecular, Inc. : November 10, 2017
finance.yahoo.com - November 11 at 11:54 AM
Edited Transcript of IMI earnings conference call or presentation 2-Nov-17 9:00pm GMTEdited Transcript of IMI earnings conference call or presentation 2-Nov-17 9:00pm GMT
finance.yahoo.com - November 5 at 7:22 PM
Intermoleculars (IMI) CEO Chris Kramer on Q3 2017 Results - Earnings Call TranscriptIntermolecular's (IMI) CEO Chris Kramer on Q3 2017 Results - Earnings Call Transcript
seekingalpha.com - November 4 at 2:13 AM
Intermolecular Announces Third Quarter 2017 Financial ResultsIntermolecular Announces Third Quarter 2017 Financial Results
www.bizjournals.com - November 3 at 9:46 AM
Intermolecular, Inc. (IMI) Set to Announce Quarterly Earnings on ThursdayIntermolecular, Inc. (IMI) Set to Announce Quarterly Earnings on Thursday
www.americanbankingnews.com - October 26 at 5:51 AM
Intermolecular To Report Third Quarter Fiscal 2017 Financial Results on November 2, 2017Intermolecular To Report Third Quarter Fiscal 2017 Financial Results on November 2, 2017
finance.yahoo.com - October 18 at 1:14 AM
Applied Micro Circuits (AMCC) & Intermolecular (IMI) Head-To-Head AnalysisApplied Micro Circuits (AMCC) & Intermolecular (IMI) Head-To-Head Analysis
www.americanbankingnews.com - October 17 at 12:56 PM
ETFs with exposure to Intermolecular, Inc. : October 10, 2017ETFs with exposure to Intermolecular, Inc. : October 10, 2017
finance.yahoo.com - October 10 at 7:14 PM
Intermolecular (IMI) versus Coherent (COHR) Head-To-Head ReviewIntermolecular (IMI) versus Coherent (COHR) Head-To-Head Review
www.americanbankingnews.com - October 8 at 8:08 PM
Intermolecular (IMI) and The Competition Head-To-Head ReviewIntermolecular (IMI) and The Competition Head-To-Head Review
www.americanbankingnews.com - September 28 at 2:28 PM
What Does Intermolecular Inc’s (IMI) Share Price Indicate?What Does Intermolecular Inc’s (IMI) Share Price Indicate?
finance.yahoo.com - September 15 at 12:47 AM
Intermolecular, Inc. (IMI) Major Shareholder Lloyd I. Miller III Buys 34,109 SharesIntermolecular, Inc. (IMI) Major Shareholder Lloyd I. Miller III Buys 34,109 Shares
www.americanbankingnews.com - September 5 at 1:38 PM
ETFs with exposure to Intermolecular, Inc. : August 31, 2017ETFs with exposure to Intermolecular, Inc. : August 31, 2017
finance.yahoo.com - August 31 at 7:49 PM
Intermolecular, Inc. :IMI-US: Earnings Analysis: Q2, 2017 By the Numbers : August 25, 2017Intermolecular, Inc. :IMI-US: Earnings Analysis: Q2, 2017 By the Numbers : August 25, 2017
finance.yahoo.com - August 26 at 6:13 AM
Intermolecular to Present at the 6th Annual Liolios Gateway Conference on September 6, 2017Intermolecular to Present at the 6th Annual Liolios Gateway Conference on September 6, 2017
finance.yahoo.com - August 25 at 7:05 AM
Intermolecular (IMI) versus Exar (EXAR) Head-To-Head SurveyIntermolecular (IMI) versus Exar (EXAR) Head-To-Head Survey
www.americanbankingnews.com - August 18 at 12:22 AM
Edited Transcript of IMI earnings conference call or presentation 8-Aug-17 9:00pm GMTEdited Transcript of IMI earnings conference call or presentation 8-Aug-17 9:00pm GMT
finance.yahoo.com - August 9 at 5:34 AM
Intermolecular Announces Second Quarter 2017 Financial ResultsIntermolecular Announces Second Quarter 2017 Financial Results
finance.yahoo.com - August 8 at 7:30 PM
Intermoleculars High-Throughput Experimentation Platform Speeds Discovery of Next-Generation Non-Volatile MemoriesIntermolecular's High-Throughput Experimentation Platform Speeds Discovery of Next-Generation Non-Volatile Memories
finance.yahoo.com - August 1 at 3:25 PM
Intermolecular To Report Second Quarter Fiscal 2017 Financial Results on August 8, 2017Intermolecular To Report Second Quarter Fiscal 2017 Financial Results on August 8, 2017
finance.yahoo.com - July 14 at 3:50 AM
Intermolecular reports 1Q lossIntermolecular reports 1Q loss
marketbeat.com - May 4 at 7:57 PM
Intermolecular Announces Restructuring Initiative and Changes in its Leadership TeamIntermolecular Announces Restructuring Initiative and Changes in its Leadership Team
us.rd.yahoo.com - March 29 at 6:25 PM
4:18 pm Intermolecular appoints Bill Roeschlein, currently VP of Finance and Corporate Controller, as CFO; also announces restructuring initiative that will lower costs by approx. $4 mln in 20174:18 pm Intermolecular appoints Bill Roeschlein, currently VP of Finance and Corporate Controller, as CFO; also announces restructuring initiative that will lower costs by approx. $4 mln in 2017
us.rd.yahoo.com - March 29 at 6:25 PM
INTERMOLECULAR INC Files SEC form 8-K, Costs Associated with Exit or Disposal Activities, Change in Directors or PrinINTERMOLECULAR INC Files SEC form 8-K, Costs Associated with Exit or Disposal Activities, Change in Directors or Prin
biz.yahoo.com - March 29 at 6:25 PM
INTERMOLECULAR INC Files SEC form 10-K, Annual ReportINTERMOLECULAR INC Files SEC form 10-K, Annual Report
biz.yahoo.com - March 3 at 5:53 PM
Q4 2016 Intermolecular Inc Earnings Release - After Market CloseQ4 2016 Intermolecular Inc Earnings Release - After Market Close
us.rd.yahoo.com - February 10 at 6:39 PM
INTERMOLECULAR INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and ExhibiINTERMOLECULAR INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibi
us.rd.yahoo.com - February 10 at 6:39 PM
Intermolecular Announces Fourth Quarter 2016 and Full Year 2016 Financial ResultsIntermolecular Announces Fourth Quarter 2016 and Full Year 2016 Financial Results
www.bizjournals.com - February 9 at 6:49 PM
INTERMOLECULAR INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and ExhibitsINTERMOLECULAR INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and Exhibits
biz.yahoo.com - November 16 at 5:52 PM

SEC Filings

Intermolecular (NASDAQ:IMI) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Intermolecular (NASDAQ:IMI) Income Statement, Balance Sheet and Cash Flow Statement

Chart

Intermolecular (NASDAQ IMI) Stock Chart for Friday, April, 20, 2018

Loading chart…

This page was last updated on 4/20/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.